BioAmber (BIOA) Tops Q3 EPS by 14c

BioAmber (NYSE: BIOA) reported Q3 EPS of ($0.27), $0.14 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $300 thousand versus the consensus estimate of $2.3 million.

For earnings history and earnings-related data on BioAmber (BIOA) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• Petco Health and Wellness (WOOF) Misses Q1 EPS by 6c
• Amtech Systems closes $60 million public stock offering